FDA Issues Information Collection Notice on Rare Pediatric Disease Priority Review Voucher
March 14, 2026
March 14, 2026
WASHINGTON, March 14 (TNSinfo) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following information collection:
SUMMARY:
The Food and Drug Administration (FDA) is announcing the issuance of approval of a product redeeming a priority review voucher. The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to award priority review vouchers to sponsors of approved rare pediatric disease product applications that me . . .
SUMMARY:
The Food and Drug Administration (FDA) is announcing the issuance of approval of a product redeeming a priority review voucher. The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to award priority review vouchers to sponsors of approved rare pediatric disease product applications that me . . .